TrialFuture oncology (London, England)2021
Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for
Masahiro Tsuboi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
123 papers cite itlatest 60 shown
this paperpooled ittrialcites it